JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266717

Human UTP11L knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

UTP11 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and Insertion of the selection cassette in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human UTP11L knockout HEK-293T cell line (AB266717)
  • Sanger seq

Unknown

Sanger Sequencing - Human UTP11L knockout HEK-293T cell line (AB266717)

Allele-2 : Insertion of the selection cassette in exon 1.

Sanger Sequencing - Human UTP11L knockout HEK-293T cell line (AB266717)
  • Sanger seq

Unknown

Sanger Sequencing - Human UTP11L knockout HEK-293T cell line (AB266717)

Allele-1 : 1 bp insertion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 1 and Insertion of the selection cassette in exon 1

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266717-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266717 Human UTP11L knockout HEK-293T cell line", "number":"AB266717-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266717-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266717-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266717-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266717 Human UTP11L knockout HEK-293T cell line", "number":"AB266717-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266717-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266717 Human UTP11L knockout HEK-293T cell line", "number":"AB266717-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266717-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266717 Human UTP11L knockout HEK-293T cell line", "number":"AB266717-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
UTP11
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

UTP11L also known as U3 small nucleolar RNA-associated protein 11-like is an RNA-binding protein with a molecular weight of approximately 80 kDa. It is expressed in various tissues but shows higher expression in brain and testis. The protein plays a mechanical role in the processing of small nucleolar RNAs where it is involved in their maturation. This RNA-binding ability enables UTP11L to participate actively in ribonucleoprotein complex formations and interact with other molecules in nucleolar compartments.
Biological function summary

UTP11L functions as an essential component of the U3 small nucleolar ribonucleoprotein (snoRNP) complex. This complex plays a pivotal role in the early cleavage steps of pre-rRNA processing an important stage in ribosome biogenesis. UTP11L facilitates the proper assembly and stabilization of this complex ensuring efficient processing of rRNA precursors into functional ribosomal RNA. These processes occur within the nucleolus the main hub for ribosome production in the cell.

Pathways

UTP11L is integral to the ribosome biogenesis and RNA processing pathways. Its interaction with the snoRNP components such as fibrillarin and NOP56 highlights its involvement in the maturation of 18S rRNA an important step for ribosomal subunit assembly. Through these pathways UTP11L aligns with other ribosomal proteins and snoRNP-associated factors playing an extensive role in maintaining the fidelity and efficiency of ribosomal function.

Studies link UTP11L to conditions such as neurodevelopmental disorders and reproductive dysfunctions. Altered expression of UTP11L or its misregulation may contribute to these pathological states by disrupting normal ribosomal assembly and function. Moreover its association with proteins like nucleolin and NOP56 in these contexts implies that changes in such interactions could impact cellular homeostasis leading to disease manifestation. Researchers continue to investigate UTP11L's role in these disorders to potentially target it for therapeutic interventions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com